[Evaluation of one month treatment with flunisolide in perennial allergic rhinitis].
The study was carried out on a group of 20 patients ages 10-44. Syntaris was administered twice daily in a total dose of 100 mcg. Rhinitis symptoms were assessed by subjective scoring (graded 0-3) and by objective measurement of nasal airflow using anterior rhinomanometry. Syntaris proved to be a safe and effective drug particularly in improving nasal patency.
Sopel
R
R
Zakładu Alergologii PSK Nr 1 w Gdańsku.
Mincewicz
G
G
Lewandowski
D
D
D000293:Adolescent; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002648:Child; D004334:Drug Administration Schedule; D005260:Female; D005446:Fluocinolone Acetonide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D012123:Pulmonary Ventilation / Q000502:physiology; D012221:Rhinitis, Allergic, Perennial / Q000188:drug therapy* / Q000503:physiopathology
D000893:Anti-Inflammatory Agents; D005446:Fluocinolone Acetonide; C007734:flunisolide
Ocena jednomiesiecznego leczenia flunizolidem w całorocznym alergicznym niezycie nosa.